Cantitate/Preț
Produs

Influenza Vaccines for the Future: Birkhäuser Advances in Infectious Diseases

Editat de Rino Rappuoli, Giuseppe Del Giudice
en Limba Engleză Hardback – 30 oct 2010
The emergence of H5N1 avian influenza in 1997 and of the influenza A H1N1 of swine origin in 2009 calls for new, rapid and sustainable solutions for both seasonal and pandemic influenza viruses. During the last ten years, science and technology have made enormous progress, and we are now able to monitor in real time the genetics of viruses while they spread globally, to make more powerful vaccines using novel adjuvants, and to generate viruses in the laboratory using reverse genetics. This volume not only provides state-of-the-art information on the biology of influenza viruses and on influenza vaccines, but is also designed to be a resource to face the present H1N1 pandemic and to plan for long-term global and sustainable solutions.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 115971 lei  6-8 săpt.
  Springer – 14 mar 2012 115971 lei  6-8 săpt.
Hardback (1) 116403 lei  6-8 săpt.
  Springer – 30 oct 2010 116403 lei  6-8 săpt.

Din seria Birkhäuser Advances in Infectious Diseases

Preț: 116403 lei

Preț vechi: 141955 lei
-18% Nou

Puncte Express: 1746

Preț estimativ în valută:
22281 23957$ 18575£

Carte tipărită la comandă

Livrare economică 19 decembrie 24 - 02 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783034602785
ISBN-10: 3034602782
Pagini: 440
Ilustrații: XIV, 446 p. 70 illus., 30 illus. in color.
Dimensiuni: 155 x 235 x 35 mm
Greutate: 0.77 kg
Ediția:2nd ed. 2011
Editura: Springer
Colecția Springer
Seria Birkhäuser Advances in Infectious Diseases

Locul publicării:Basel, Switzerland

Public țintă

Research

Cuprins

EVOLUTION AND EPIDEMIOLOGY.- Influenza Virus: The Biology of a Changing Virus.- The Epidemiology of Influenza and its Control.- Epidemiology of Influenza in Tropical and Sub-Tropical Low Income Regions.- The Origin and Evolution of H1N1 Pandemic Influenza Viruses.- The Emergence of 2009 H1N1 Pandemic Influenza.- IMMUNITY AND VACCINE STRATEGIES.- Influenza Vaccines have Short but Illustrious History of Dedicated Science Enabling the Rapid Global Production of A/Swine (H1N1) Vaccine in the Current Pandemic.- Influenza and Influenza Vaccination in Children.- The Immune Response to Influenza A Viruses.- Correlates of Protection Against Influenza.- The Role of Animal Models in Influenza Vaccine Research.- Live Attenuated Influenza Vaccine.- Cell Culture-Derived Influenza Vaccines.- Conserved Internal Proteins as Potential Universal Vaccines.- Adjuvants for Influenza Vaccines: The Role of Oil-in-Water Adjuvants.- Lesson Learned from Clinical Trials in 1976 and 1977 with Vaccines for the Newly Emerged Swine and Russian Influenza A/H1N1 Viruses.- Human Monoclonal Antibodies for Prophylaxis and Treatment of Influenza.- ECONOMIC AND SOCIAL IMPLICATIONS.- Learning from the First Pandemic of the 21st Century.- Economic Implications of Influenza and Influenza Vaccine.

Recenzii

From the reviews of the second edition:
“What the book delivered was a curious juxtaposition of historical perspective alongside a modern commercial approach: from what went wrong in the swine flu vaccination incident of 1976 in the USA, to which companies are using M2 protein conjugates. … This type of information is quite hard to glean from the academic literature. It was also great to get solid information about the state of the art today … . Overall there is some useful detail in this book that is hard to get elsewhere.” (Wendy Barclay, Microbiology Today, May, 2011)

Textul de pe ultima copertă

The emergence of H5N1 avian influenza in 1997 and of the influenza A H1N1 of swine origin in 2009 calls for new, rapid and sustainable solutions for both seasonal and pandemic influenza viruses. During the last ten years, science and technology have made enormous progress, and we are now able to monitor in real time the genetics of viruses while they spread globally, to make more powerful vaccines using novel adjuvants, and to generate viruses in the laboratory using reverse genetics. This volume not only provides state-of-the-art information on the biology of influenza viruses and on influenza vaccines, but is also designed to be a resource to face the present H1N1 pandemic and to plan for long-term global and sustainable solutions.

Caracteristici

Presents new vaccination strategies in the light of the most recent outbreak Presents a thorough discussion on immune response and correlates of protection Provides an overview of epidemiology and the control of influenza Includes supplementary material: sn.pub/extras